PRMT1 interacts with AML1-ETO to promote its transcriptional activation and progenitor cell proliferative potential.

Fusion protein AML1-ETO, resulting from t(8;21) translocation, is highly related to leukemia development. It has been reported that full-length AML1-ETO blocks AML1 function and requires additional mutagenic events to promote leukemia. We have previously shown that the expression of AE9a, a splice isoform of AML1-ETO, can rapidly cause leukemia in mice. To understand how AML1-ETO is involved in leukemia development, we took advantage of our AE9a leukemia model and sought to identify its interacting proteins from primary leukemic cells. Here, we report the discovery of a novel AE9a binding partner PRMT1 (protein arginine methyltransferase 1). PRMT1 not only interacts with but also weakly methylates arginine 142 of AE9a. Knockdown of PRMT1 affects expression of a specific group of AE9a-activated genes. We also show that AE9a recruits PRMT1 to promoters of AE9a-activated genes, resulting in enrichment of H4 arginine 3 methylation, H3 Lys9/14 acetylation, and transcription activation. More importantly, knockdown of PRMT1 suppresses the self-renewal capability of AE9a, suggesting a potential role of PRMT1 in regulating leukemia development.

[1]  A. Melnick,et al.  The Leukemogenicity of AML1-ETO Is Dependent on Site-Specific Lysine Acetylation , 2011, Science.

[2]  Natalia Meani,et al.  Acute myeloid leukemia fusion proteins deregulate genes involved in stem cell maintenance and DNA repair. , 2003, The Journal of clinical investigation.

[3]  A. Scorilas,et al.  The PRMT1 gene expression pattern in colon cancer , 2008, British Journal of Cancer.

[4]  J. Yates,et al.  Large-scale analysis of the yeast proteome by multidimensional protein identification technology , 2001, Nature Biotechnology.

[5]  J. Workman,et al.  Preparation of Nuclear and Cytoplasmic Extracts from Mammalian Cells , 1993, Current protocols in molecular biology.

[6]  Mark T Bedford,et al.  Arginine methylation an emerging regulator of protein function. , 2005, Molecular cell.

[7]  M. Stallcup,et al.  Synergistic Enhancement of Nuclear Receptor Function by p160 Coactivators and Two Coactivators with Protein Methyltransferase Activities* , 2001, The Journal of Biological Chemistry.

[8]  K. Mills,et al.  Transcriptional dysregulation mediated by RUNX1-RUNX1T1 in normal human progenitor cells and in acute myeloid leukaemia , 2007, Leukemia.

[9]  S. Malik,et al.  Two functional modes of a nuclear receptor-recruited arginine methyltransferase in transcriptional activation. , 2006, Molecular cell.

[10]  James R. Downing,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Makes Distinct Contacts with Multiple Histone Deacetylases and Binds mSin3A through Its Oligomerization Domain , 2001, Molecular and Cellular Biology.

[11]  A. Boyapati,et al.  Cell type dependent regulation of multidrug resistance-1 gene expression by AML1-ETO. , 2007, Blood cells, molecules & diseases.

[12]  I. Weissman,et al.  AML1-ETO expression is directly involved in the development of acute myeloid leukemia in the presence of additional mutations , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[13]  J. Downing,et al.  Expression of a conditional AML1-ETO oncogene bypasses embryonic lethality and establishes a murine model of human t(8;21) acute myeloid leukemia. , 2002, Cancer cell.

[14]  M. Cleary,et al.  MLL-AFX Requires the Transcriptional Effector Domains of AFX To Transform Myeloid Progenitors and Transdominantly Interfere with Forkhead Protein Function , 2002, Molecular and Cellular Biology.

[15]  B. Ponder,et al.  Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancers , 2011, International journal of cancer.

[16]  M. Grez,et al.  Multiple Regions of ETO Cooperate in Transcriptional Repression* , 2001, The Journal of Biological Chemistry.

[17]  R. Roeder,et al.  Ordered Cooperative Functions of PRMT1, p300, and CARM1 in Transcriptional Activation by p53 , 2004, Cell.

[18]  O. Heidenreich,et al.  siRNA-mediated AML1/MTG8 depletion affects differentiation and proliferation-associated gene expression in t(8;21)-positive cell lines and primary AML blasts , 2006, Oncogene.

[19]  Christian Gilissen,et al.  BTG1 regulates glucocorticoid receptor autoinduction in acute lymphoblastic leukemia. , 2010, Blood.

[20]  C. Glass,et al.  ETO, a Target of t(8;21) in Acute Leukemia, Interacts with the N-CoR and mSin3 Corepressors , 1998, Molecular and Cellular Biology.

[21]  C. Allis,et al.  Methylation of RUNX1 by PRMT1 abrogates SIN3A binding and potentiates its transcriptional activity. , 2008, Genes & development.

[22]  Ming Yan,et al.  A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis , 2006, Nature Medicine.

[23]  Shiaw-Min Hwang,et al.  Protein-arginine Methyltransferase 1 Suppresses Megakaryocytic Differentiation via Modulation of the p38 MAPK Pathway in K562 Cells* , 2010, The Journal of Biological Chemistry.

[24]  G. Felsenfeld,et al.  H4R3 methylation facilitates beta-globin transcription by regulating histone acetyltransferase binding and H3 acetylation. , 2010, Blood.

[25]  Michael Q. Zhang,et al.  A global transcriptional regulatory role for c-Myc in Burkitt's lymphoma cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[26]  L. Peterson,et al.  t(8;21)(q22;q22) Fusion proteins preferentially bind to duplicated AML1/RUNX1 DNA-binding sequences to differentially regulate gene expression. , 2008, Blood.

[27]  C. Allis,et al.  Methylation of Histone H4 at Arginine 3 Facilitating Transcriptional Activation by Nuclear Hormone Receptor , 2001, Science.

[28]  H R Herschman,et al.  PRMT1 Is the Predominant Type I Protein Arginine Methyltransferase in Mammalian Cells* , 2000, The Journal of Biological Chemistry.

[29]  M. Cleary,et al.  Protein arginine-methyltransferase-dependent oncogenesis , 2007, Nature Cell Biology.

[30]  U. Bauer,et al.  The protein arginine methyltransferases CARM1 and PRMT1 cooperate in gene regulation , 2008, Nucleic acids research.

[31]  J. Bravo,et al.  Mutagenesis of the Runt Domain Defines Two Energetic Hot Spots for Heterodimerization with the Core Binding Factor β Subunit* , 2003, Journal of Biological Chemistry.

[32]  J. Downing,et al.  Expression of a knocked-in AML1-ETO leukemia gene inhibits the establishment of normal definitive hematopoiesis and directly generates dysplastic hematopoietic progenitors. , 1998, Blood.

[33]  T. Hoshino,et al.  ETO, fusion partner in t(8;21) acute myeloid leukemia, represses transcription by interaction with the human N-CoR/mSin3/HDAC1 complex. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[34]  T. Kouzarides.  Chromatin Modifications and Their Function , 2007, Cell.

[35]  Z. Dauter,et al.  The tetramer structure of the Nervy homology two domain, NHR2, is critical for AML1/ETO's activity. , 2006, Cancer cell.

[36]  G. Felsenfeld,et al.  Methylation of histone H4 by arginine methyltransferase PRMT1 is essential in vivo for many subsequent histone modifications. , 2005, Genes & development.

[37]  E. Venturini,et al.  AML1/ETO Oncoprotein Is Directed to AML1 Binding Regions and Co-Localizes with AML1 and HEB on Its Targets , 2008, PLoS genetics.

[38]  J. Bravo,et al.  Energetic Contribution of Residues in the Runx1 Runt Domain to DNA Binding* , 2003, Journal of Biological Chemistry.

[39]  H. Gehring,et al.  Protein arginine methylation: Cellular functions and methods of analysis. , 2006, Biochimica et biophysica acta.

[40]  Cyrus Martin,et al.  The diverse functions of histone lysine methylation , 2005, Nature Reviews Molecular Cell Biology.

[41]  Rowley Jd.  Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. , 1973 .

[42]  M. Bedford,et al.  Techniques in protein methylation. , 2004, Methods in molecular biology.

[43]  A. Warren,et al.  Hematopoietic Stem Cell Expansion and Distinct Myeloid Developmental Abnormalities in a Murine Model of the AML1-ETO Translocation , 2002, Molecular and Cellular Biology.

[44]  Ming Yan,et al.  Deletion of an AML1-ETO C-terminal NcoR/SMRT-interacting region strongly induces leukemia development. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[45]  S. Minucci,et al.  Aberrant Recruitment of the Nuclear Receptor Corepressor-Histone Deacetylase Complex by the Acute Myeloid Leukemia Fusion Partner ETO , 1998, Molecular and Cellular Biology.

[46]  M. Ohki,et al.  t(8;21) breakpoints on chromosome 21 in acute myeloid leukemia are clustered within a limited region of a single gene, AML1. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[47]  C. Stocking,et al.  AML1-ETO Inhibits Maturation of Multiple Lymphohematopoietic Lineages and Induces Myeloblast Transformation in Synergy with ICSBP Deficiency , 2002, The Journal of experimental medicine.

[48]  Wen‐Ming Yang,et al.  Transcriptional repression by YY1 is mediated by interaction with a mammalian homolog of the yeast global regulator RPD3. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[49]  E. Wahle,et al.  Unusual Sites of Arginine Methylation in Poly(A)-binding Protein II and in Vitro Methylation by Protein Arginine Methyltransferases PRMT1 and PRMT3* , 1999, The Journal of Biological Chemistry.

[50]  Ming Yan,et al.  Acute myeloid leukemia with the 8q22;21q22 translocation: secondary mutational events and alternative t(8;21) transcripts. , 2007, Blood.

[51]  S. Horvath,et al.  Global histone modification patterns predict risk of prostate cancer recurrence , 2005, Nature.

[52]  J. Rowley.  Identificaton of a translocation with quinacrine fluorescence in a patient with acute leukemia. , 1973, Annales de genetique.